Cost Analysis: Port Delivery System versus Monthly Ranibizumab for Wet Age-Related Macular Degeneration Treatment

Journal article

Peer reviewed

Hasenin Al-khersan, Nimesh A. Patel, Nicolas A. Yannuzzi, James Lin and William E. Smiddy

Ophthalmology retina

2022-05

PMID: 35636743

Abstract

Age-related macular degeneration

Cost analysis

Intravitreal injection

Ranibizumab

9 Record Views

Title: Cost Analysis: Port Delivery System versus Monthly Ranibizumab for Wet Age-Related Macular Degeneration Treatment
Creators: Hasenin Al-khersan - University of Miami
Nimesh A. Patel - Massachusetts Eye and Ear Infirmary
Nicolas A. Yannuzzi - University of Miami
James Lin - Vitreous Retina Macula Consultants of New York
William E. Smiddy - University of Miami
Publication Details: Ophthalmology retina
Publisher: Elsevier Inc
Academic Unit: UMMG Department of Ophthalmology; Miller School of Medicine
Language: English
Resource Type: Journal article
PMID: 35636743
Record Identifier: 991031723510602976